Zobrazeno 1 - 10
of 104
pro vyhledávání: '"DANIEL R TOUCHETTE"'
Autor:
Sun A Choi, Kandavadivu Umashankar, Anjana Maheswaran, Michelle T Martin, Jean Lee, Matt Odishoo, Janet Y Lin, Daniel R Touchette
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background In the United States (US), hepatitis C virus (HCV) screening is not covered by payers in settings outside of primary care. A non-traditional, emergency department (ED)-based HCV screening program can be cost-effective and identify
Externí odkaz:
https://doaj.org/article/31ca22f582de4eb6854685f5cab4c792
Autor:
Mrinmayee, Joshi, Steven J, Atlas, Molly, Beinfeld, Richard H, Chapman, David M, Rind, Steven D, Pearson, Daniel R, Touchette
Publikováno v:
Value in Health. 26:823-832
Nadofaragene firadenovec is a gene therapy for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) undergoing FDA review. Pembrolizumab is approved for treating BCG-unresponsive NMIBC patients with carcinoma in-situ (CIS). We evaluated the co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d63e57b91ddb2390e720a02355ab106
https://doi.org/10.1016/j.jval.2022.12.005
https://doi.org/10.1016/j.jval.2022.12.005
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6:416-426
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fa74974d976ce124f94500ea35bd7a9
https://doi.org/10.1002/jac5.1771
https://doi.org/10.1002/jac5.1771
Autor:
Dolly Sharma, Shan Xing, Yu-Ting Hung, Rachel N. Caskey, Maria L. Dowell, Daniel R. Touchette
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-12 (2018)
Abstract Background Lumacaftor/ivacaftor was approved by the Food and Drug Administration (FDA) as a combination treatment for Cystic Fibrosis (CF) patients who are homozygous for the F508del mutation. The objective of this study was to assess the co
Externí odkaz:
https://doaj.org/article/99c6326b8cad4f8e9bbb9ab43aa7c36a
Autor:
Jeffrey A Tice, Daniel R Touchette, Pei-Wen Lien, Foluso Agboola, Dmitriy Nikitin, Steven D Pearson
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:119-124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e5881f17dbd6236132c37eb71c0ce78
https://doi.org/10.18553/jmcp.2022.28.1.119
https://doi.org/10.18553/jmcp.2022.28.1.119
Autor:
Daniel R. Touchette, Ryan Rodriguez
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4:1624-1630
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5d6ce57cdf5b4b73c2b5e4fad3e446b
https://doi.org/10.1002/jac5.1562
https://doi.org/10.1002/jac5.1562
Autor:
Pritesh R. Patel, Gregory S. Calip, Todd A. Lee, Brian Talon, Daniel R. Touchette, Lisa K. Sharp
Publikováno v:
JCO Oncol Pract
PURPOSE: Treatment of chronic myelogenous leukemia (CML) with tyrosine kinase inhibitors (TKIs) has improved survival but is associated with significant financial burden. We measured the annual trend in TKI utilization, Medicare gross payment, and pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2581876874cf1b8dc9f91efed5913d32
https://doi.org/10.1200/op.20.00967
https://doi.org/10.1200/op.20.00967
Autor:
Kristin A Evans, Michael Pollack, Edward Portillo, Charlie Strange, Daniel R Touchette, Anthony Staresinic, Sushma Patel, Joseph Tkacz, Norbert Feigler
Publikováno v:
Journal of managed carespecialty pharmacy. 28(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c97b58cd4f1f506d31f4171e7315dff
https://pubmed.ncbi.nlm.nih.gov/36427341
https://pubmed.ncbi.nlm.nih.gov/36427341
Autor:
Daniel R. Touchette, David Rind, Avery McKenna, Steven D. Pearson, Steven J. Atlas, Molly Beinfeld
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 27:797-804
DISCLOSURES: Funding for this summary was contributed by Arnold Ventures, California Health Care Foundation, The Donaghue Foundation, Harvard Pilgrim Health Care, and Kaiser Foundation Health Plan to the Institute for Clinical and Economic Review (IC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c374080d61162816325330f5f0b2be1f
https://doi.org/10.18553/jmcp.2021.27.6.797
https://doi.org/10.18553/jmcp.2021.27.6.797
Autor:
Danny Quach, Tiffany Scott-Horton, Daniel R. Touchette, Jessica J. Tilton, Julie Jun, Bob G. Schultz
Publikováno v:
Value in Health. 24:522-529
Objectives Uncontrolled hypertension is a common cause of cardiovascular disease, which is the deadliest and costliest chronic disease in the United States. Pharmacists are an accessible community healthcare resource and are equipped with clinical sk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a395010b27da1def65e6f231b0258f6
https://doi.org/10.1016/j.jval.2020.10.008
https://doi.org/10.1016/j.jval.2020.10.008